Scott Atlas resigns as particular adviser to Trump on coronavirus

2/2

© Reuters. Trump coronavirus disease advisor Dr. Scott Atlas walks outside the White House in Washington

2/2

WASHINGTON (Reuters) – Dr. Scott Atlas (NYSE:) has resigned as special adviser to President Donald Trump, a White House official said on Monday, after a controversial four months during which he clashed repeatedly with other members of the coronavirus task force.

“I am writing to resign from my position as special adviser to the president of the United States,” Atlas said in a letter to Trump dated Dec. 1, according to Fox News, which first reported his resignation.

Atlas was considered a special government employee on a 130-day detail that expires this week.

Atlas, a neuroradiologist, apologized on Twitter this month for giving an interview to Russia’s Kremlin-backed television station RT, saying he was unaware it was a registered foreign agent in the United States.

Atlas has been sharply criticized by public health experts, including Anthony Fauci, the leading U.S. infectious disease expert, for providing Trump with misleading or incorrect information on the virus pandemic.

He has repeatedly downplayed the importance of face masks and this month said lockdowns had been “an epic failure” in stopping the spread of the virus.

His views on the handling of the pandemic have been denounced by peers at Stanford University’s medical school and elsewhere.

(Interactive graphic tracking global spread of coronavirus: https://graphics.reuters.com/world-coronavirus-tracker-and-maps)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Comments are closed.